✦ LIBER ✦

PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING

✍ Scribed by C. Craver; J. Gayle; S. Balu; D. Buchner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN2 PALONOSETRON VERSUS OTHER 5-HT3-REC

✍ C Craver; J Gayle; S Balu; D Buchner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Palonosetron Versus Other 5-HT3 Receptor

✍ Sanjeev Balu; Deborah Buchner; Chris Craver; Julie Gayle 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 621 KB

Abstract PA-2: Cost Consequences of Init

✍ Sanjeev Balu; Chris Craver; Julie Gayle; Deborah Buchner 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 125 KB

PCN48 IMPACT ON HOSPITAL OUTPATIENT VISI

✍ C. Craver; J. Gayle; S. Balu; D. Buchner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB